The Superior Court of New Jersey Appellate Division has thrown out a $223.8M verdict against Johnson & Johnson in a trial over four plaintiffs’ claims that they developed cancer from being exposed to the company’s talc powder products, finding that a lower court judge should not have allowed some of the scientific expert testimony the plaintiffs presented to jurors in the case, reported Reuters’ Brendan Pierson.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JNJ: